SMTL ID : 4bci.1

Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.10 Å

Oligo State

hetero-1-1-mer

Ligands

1 x T3E: 3-[[5-cyano-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide(Non-covalent)

T3E.1: 12 residues within 4Å: Chain A: I.26, F.31, A.47, V.80, F.104, D.105, F.106, C.107, E.108, H.109, L.157, D.168 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:F.104, A:L.157 Hydrogen bonds: A:C.107, A:C.107, A:E.108, A:D.168, A:D.168

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hole, A.J. et al., Comparative Structural and Functional Studies of 4-(Thiazol- 5-Yl)-2-(Phenylamino)Pyrimidine-5-Carbonitrile Cdk9 Inhibitors Suggest the Basis for Isotype Selectivity. J.Med.Chem. (2013)

Release Date

2013-01-09

Peptides

CYCLIN-DEPENDENT KINASE 9: A
CYCLIN-T1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

CYCLIN-DEPENDENT KINASE 9

CYCLIN-T1

Related Entries With Identical Sequence